IsoRay Hits New High: Should You Buy Right Now?

One of the stocks to have made eye-catching gains over the course of the past week is that of radiation therapy development company IsoRay, Inc. (NYSE: ISR). The stock has surged by as much as 400% over the course of the past week after a key development.

IsoRay Hits New High: Should You Buy Right Now?

Back on January 6, it emerged that the United States Food and Drug Administration awarded the clearance for using Isoray’s brachytherapy seeds in conjunction with MRI markets for treating prostate cancer by C4 Therapeutics.

It goes without saying that it is a major development for the company and one that has brought Isoray into sharp focus among investors. The stock rallied by as much as 19% on Monday as well.

However, it has suffered a slight decline during premarket trade this morning, and hence; it is something that investors are going to be watching closely. It remains to be seen if the dip during premarket trading today is a correction or a minor bump.

IsoRay Hits New High: Should You Buy Right Now?

Emile Ortega

Editor and Computer ExpertA hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.